Xintela develops unique methods in stem cell therapy for the brain and broadens patent portfolio

Link to full story from manufacturer’s website

Maybe we can take this thing in the future and hope that it can regenerate our brain cells… :relaxed::relaxed:

“We believe this has very large potential and plan for further development once resources are available, either internally or through external collaboration partners,” says Xintela’s CEO Evy Lundgren-Åkerlund.

The results arose from the Company’s ongoing research and development within regenerative medicine using its patented integrin marker technology. The new methods which have been developed on neural stem cells from mice, provide exiting prospects for stem cell therapy for regeneration of tissue after stroke or after trauma of the brain or spinal cord, as well as for the treatment or amelioration of symptoms in neurodegenerative diseases such as Alzheimer’s and Parkinson’s. Each of these indications is recognized as having very high unmet medical need and significant commercial potential.

5 Likes

Havent said anything about sz. HOLY COW.